Actively Recruiting
Bladder EpiCheck Product Development Study
Led by Nucleix Ltd. · Updated on 2026-04-07
1000
Participants Needed
2
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, observational study to support the development of the Bladder EpiCheck kit by collecting urine samples from subjects suspected to have a bladder tumor or under NMIBC surveillance. This is a single visit study. Each subject will sign the informed consent and provide voided urine sample. Demography and, if performed, pathology information will be collected for each subject.
CONDITIONS
Official Title
Bladder EpiCheck Product Development Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 22 or older
- Willing and able to sign the informed consent form
- Planned to undergo within 60 days one of the following: TURBT for suspected or detected bladder tumor, cystoscopy under general anesthesia for suspected bladder tumor, or cystoscopy for NMIBC surveillance
You will not qualify if you...
- Known or history of muscle invasive bladder cancer (MIBC)
- Treatment of prostate cancer or renal cell carcinoma (RCC) in the past 2 years
- Previously enrolled in this study within the prior 60 days
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Om Research LLC
San Diego, California, United States, 92103
Actively Recruiting
2
Chesapeake Urology Research Associates
Towson, Maryland, United States, 21204
Actively Recruiting
Research Team
L
Limor Klein, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here